Clinical Research Solutions
				
				Jackson, Tennessee 38305
We've found
        7 trials
        at this facility
      	
	Irritable Bowel Syndrome Clinical Trial
	
Updated: 12/31/1969
  
  
  Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Irritable Bowel Syndrome Clinical Trial
	
Updated: 7/6/2016
  
  
  Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 7/6/2016
Click here to add this to my saved trials
	    
	 
  	
	Gastroparesis Clinical Trial
	
Updated: 12/12/2016
  
  
  The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/12/2016
Click here to add this to my saved trials
	    
	 
  	
	Articular Cartilage of the Femoral Condyle Between 2-6cm2 Clinical Trial
	
Updated: 12/31/1969
  
  
  NOVOCART®3D for Treatment of Articular Cartilage of the Knee
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Influenza, Human Clinical Trial
	
Updated: 12/31/1969
  
  
  A Clinical Trial of KT07 Capsule in the U.S.A
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Gastroenterology, Immunology / Infectious Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Gastroesophageal Reflux Disease (GERD) Clinical Trial
	
Updated: 12/31/1969
  
  
  Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	